依维莫司在abo血型不相容肾移植中的疗效:回顾性研究

IF 0.1 Q4 TRANSPLANTATION

Transplant Research and Risk Management Pub Date : 2017-09-27 DOI:10.2147/TRRM.S137727

K. Tsujimura, M. Ota, K. Chinen, Kiyomi Nagayama, M. Oroku, Morikuni Nishihira, Y. Shiohira, K. Iseki, H. Ishida, K. Tanabe

{"title":"依维莫司在abo血型不相容肾移植中的疗效:回顾性研究","authors":"K. Tsujimura, M. Ota, K. Chinen, Kiyomi Nagayama, M. Oroku, Morikuni Nishihira, Y. Shiohira, K. Iseki, H. Ishida, K. Tanabe","doi":"10.2147/TRRM.S137727","DOIUrl":null,"url":null,"abstract":"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). Transplant Research and Risk Management 2017:9 43–48 Transplant Research and Risk Management Dovepress","PeriodicalId":41597,"journal":{"name":"Transplant Research and Risk Management","volume":"9 1","pages":"43-48"},"PeriodicalIF":0.1000,"publicationDate":"2017-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2147/TRRM.S137727","citationCount":"1","resultStr":"{\"title\":\"Efficacy of everolimus in ABO-incompatible kidney transplantation: a retrospective study\",\"authors\":\"K. Tsujimura, M. Ota, K. Chinen, Kiyomi Nagayama, M. Oroku, Morikuni Nishihira, Y. Shiohira, K. Iseki, H. Ishida, K. Tanabe\",\"doi\":\"10.2147/TRRM.S137727\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). Transplant Research and Risk Management 2017:9 43–48 Transplant Research and Risk Management Dovepress\",\"PeriodicalId\":41597,\"journal\":{\"name\":\"Transplant Research and Risk Management\",\"volume\":\"9 1\",\"pages\":\"43-48\"},\"PeriodicalIF\":0.1000,\"publicationDate\":\"2017-09-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.2147/TRRM.S137727\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Transplant Research and Risk Management\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2147/TRRM.S137727\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"TRANSPLANTATION\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transplant Research and Risk Management","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2147/TRRM.S137727","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"TRANSPLANTATION","Score":null,"Total":0}

引用次数: 1

摘要

并纳入知识共享署名-非商业(未移植，v3.0)许可证(http://creativecommons.org/licenses/by-nc/3.0/)。通过访问作品，您在此接受这些条款。允许非商业用途的工作，没有任何进一步的许可，从多芬医学出版社有限公司，只要工作适当署名。关于本作品的商业使用许可，请参阅本条款第4.2条和第5条(https://www.dovepress.com/terms.php)。移植研究与风险管理，2017 (9):43-48

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Efficacy of everolimus in ABO-incompatible kidney transplantation: a retrospective study

php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). Transplant Research and Risk Management 2017:9 43–48 Transplant Research and Risk Management Dovepress

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Transplant Research and Risk Management TRANSPLANTATION-

CiteScore

0.70

自引率

0.00%

发文量

审稿时长

16 weeks